GSA Capital Partners »

Protalix Biotherapeutics shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2024-09-30 $444k 435k 1.02
2024-06-30 $469k 401k 1.17
2024-03-31 $622k 494k 1.26
2023-12-31 $969k 544k 1.78
2023-09-30 $825k 497k 1.66
2021-12-31 $20k 25k 0.82
2021-09-30 $339k 255k 1.33
2020-12-31 $36k 10k 3.58